SCHEMBL5280671

SCHEMBL5280671

CC(C)NC(=O)c1cnc(N2CCCCC2)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.54
HDAC6 Q9UBN7 2/20 0.51
ACACB O00763 6/20 0.48
HDAC3 O15379 2/20 0.46
HDAC1 Q13547 2/20 0.46
HDAC2 Q92769 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
POLB P06746 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HDAC4 P56524 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
STK17A Q9UEE5 3/20 0.45
NEK3 P51956 1/20 0.45
LIMK1 P53667 1/20 0.45
NEK5 Q6P3R8 1/20 0.45
MYLK4 Q86YV6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25703284 0.83 HDAC3 (0.49) MAPTHDAC6HDAC3HDAC1HDAC2
SCHEMBL12395356 0.82 HDAC6 (0.61) MAPTHDAC6HDAC3HDAC1HDAC2
SCHEMBL15341329 0.81 MAPT (0.53) MAPTHDAC6ACACBPOLBSMN1; SMN2
SCHEMBL23370098 0.79 MAPT (0.54) MAPTHDAC6ACACBHDAC3HDAC1
SCHEMBL16663857 0.78 POLB (0.59) MAPTHDAC6ACACBHDAC3HDAC1
SCHEMBL25709615 0.77 HDAC6 (0.47) HDAC6HDAC3HDAC1HDAC2HDAC8
SCHEMBL186135 0.76 POLB (0.69) MAPTHDAC6POLBSMN1; SMN2KDM4E
SCHEMBL4790004 0.75 POLB (0.49) MAPTHDAC6POLBSMN1; SMN2KDM4E
SCHEMBL184998 0.74 POLB (0.71) MAPTHDAC6HDAC3HDAC1HDAC2
SCHEMBL6125266 0.74 HDAC6 (0.65) MAPTHDAC6SMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809290-A2 PYRIMIDINE DERIVATIVES AS ION CHANNEL MODULATORS AND METHODS OF USE Vertex Pharmaceuticals Incorporated (US) 2007-07-25 EP disclosed
WO-2006050476-A2 PYRIMIDINE DERIVATIVES AS ION CHANNEL MODULATORS AND METHODS OF USE VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-05-11 WO disclosed